Congress Oral Awards

Posted on by Soto Ella

Presented for Best Congress TDM and Best Congress CT Oral Presentations

The awards shall be presented to the presenters of each of two orals presented at the IATDMCT Congress.

  • One oral will be selected as the Best Oral in the field of Clinical Toxicology.
  • One oral will be selected as the Best Oral in the field of Therapeutic Drug Monitoring.

Terms of Reference

The awards shall be presented to the presenters of each of two orals presented at the IATDMCT Congress.

  • One oral will be selected as the Best Oral in the field of Clinical Toxicology and the other will be the Best Oral in the field of Therapeutic Drug Monitoring.
  • The orals selected for these awards shall be determined by an independent panel of judges.
  • The panel of judges will include the person from the Congress Organizing Committee who is responsible for abstracts (or their designates from the Organizing Committee), the Editors-in-Chief of Therapeutic Drug Monitoring (or their designate from the Editorial Board), and an IATDMCT Director of Education. The Editors-in-Chief of TDM (or their designates) will co-chair the panel. At their discretion, these judges can appoint additional judges as required.
  • An oral is eligible if at least one author is an IATDMCT member and none of the authors is a member of the panel of judges. If a judge works in the same laboratory as one of the authors, the judge must remove himself from the adjudication of that oral.
  • Each Award will consist of a certificate for the first author. The Awards will be presented at the Closing Ceremony or at some other suitable occasion during the conference.
  • The marking scheme for orals will be
    • Originality (40%),
    • Significance (20%),
    • Degree of Scientific/Technical Challenge (25%), and
    • Presentation (15%).

2015 Recipient – Congress Oral TDM

Daniel Renné, Germany

Daniel Renné, Germany

Sponsored by

IATDMCT

 

IATDMCT
Application of the AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry to Patients under Therapy with the Antipsychotics Clozapine, Olanzapine, and Risperidone in a Community Hospital in Germany
Renné D1, Bürgy M, Wieland E, Shipkova M
1Klinikum Stuttgart, Germany

Past Recipients

  • 2013 Pierre-André Billat, France
  • 2011 Hylke De Jonge, Belgium

2015 Recipient – Congress Oral CT

Michael Boettcher, Germany

Michael Boettcher, Germany

Sponsored by

IATDMCT

 

IATDMCT
Comprehensive Toxicological Analysis of Clinical Urine Samples with the ToxtyperTM Compared to a Standard GC/EI-MS-FullScan Method
Lohrmann S, Boettcher M1
1MVZ Labor Dessau GmbH, Germany

Past Recipients

  • 2013 Christope Stove, Belgium
  • 2011 Sally Hanton, United Kingdom